TOKYO/LONDON, May 30 (Reuters) - Japan set a lower-than-expected price for cancer drug Avastin, sending shares of Roche’s partner Chugai Pharmaceutical down 7 percent and underscoring pressure on the industry to keep a lid on prices of new cancer drugs.
